Parcel Health, Inc. – Trademark Portfolio

Entity Type: 03

Parcel Health, Inc. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 20 (Furniture) — 3 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 3 trademarks are registered and 1 is pending. Notable registered marks include PHILL BOX, TULLY TUBE, and PARCEL HEALTH. The owner is based in Pittsburgh, PA.

201 N. Braddock Ave

Room 126

Pittsburgh, PA 15208

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Parcel Health, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

20
Furniture (3 filings)

Furniture, mirrors, picture frames; goods of wood, cork, reed, cane, wicker

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Parcel Health, Inc. have?

Parcel Health, Inc. has 4 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 pending.

What trademark classes does Parcel Health, Inc. file in?

Parcel Health, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 20 (Furniture), Class 5 (Pharmaceuticals). Class 20 covers furniture, mirrors, picture frames; goods of wood, cork, reed, cane, wicker.

What are Parcel Health, Inc.'s most well-known trademarks?

Parcel Health, Inc.'s registered trademark portfolio includes well-known marks such as PHILL BOX, TULLY TUBE, and PARCEL HEALTH. These are among 3 currently registered trademarks in the portfolio.

What is Parcel Health, Inc.'s trademark registration success rate?

Parcel Health, Inc. has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 1 application is pending review.